Bioactive microrobot instillation therapy for bladder cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-Oct-2026 00:16 ET (26-Oct-2026 04:16 GMT/UTC)
An ultrasound-responsive micronanorobot combines a collagenase-secreting bacterium, bismuth ferrite nanoparticles, the drug DM4 and a targeting ligand to treat nonmuscle-invasive bladder cancer. After intravesical delivery, it degrades tumor matrix, enhances drug penetration, and ultrasound triggers reactive oxygen species, achieving 90.8% cell death in vitro and 82.4% tumor inhibition in mice. The system also promotes antitumor immunity, increasing CD8+ T-cell infiltration and shifting macrophages toward the M1 phenotype.
Training in AI skills improves the chances of women from underrepresented backgrounds being invited to job interviews, but not enough to eliminate the inequalities they face in the labour market, according to a new study.
New technology combines artificial intelligence and microscopy to screen cells at large scale.
Many medicines today are produced in standard doses, even though patients often have very different treatment needs. In her doctoral thesis in drug development at Åbo Akademi University, Mahsa Bahman investigated a technology that could make it easier to produce medicines tailored to individual patients, helping improve dose accuracy and access to treatment.
Bentham Books announces the release of Reshaping Banking and Financial Services with Disruptive Technologies, an insightful edited volume examining how emerging technologies are transforming financial institutions, customer experiences, risk management and the broader financial ecosystem.
A perspective published in the Journal of Bioresources and Bioproducts examines the emerging role of silk fibroin (SF)/polylactic acid (PLA) composite scaffolds in bone and related tissue regeneration. The review brings together evidence on material chemistry, scaffold architecture, interfacial bonding, degradation, mechanotransduction, osteogenesis, angiogenesis and immunomodulation. Rather than treating fabrication methods or biological responses separately, the authors discuss how these factors interact to determine scaffold performance. The review also assesses evidence across in vitro, animal and translational studies, concluding that substantial work remains before SF/PLA scaffolds can move toward human clinical applications.